Published in Ophthalmology on July 29, 2009
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
State of the art in intravesical therapy for lower urinary tract symptoms. Rev Urol (2010) 0.89
[Antiangiogenic therapy for pterygium recurrence]. Ophthalmologe (2009) 0.88
[Topical inhibition of angiogenesis at the cornea. Safety and efficacy]. Ophthalmologe (2009) 0.87
Emerging techniques to treat corneal neovascularisation. Eye (Lond) (2011) 0.82
Gap junction proteins and their role in spinal cord injury. Front Mol Neurosci (2015) 0.77
Nucleic acid drugs for prevention of cardiac rejection. J Biomed Biotechnol (2009) 0.77
Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. Surv Ophthalmol (2015) 0.77
[Pterygium. Etiology, clinical aspects and novel adjuvant therapies]. Ophthalmologe (2010) 0.76
[Late complications after chemical burns of the ocular surface. Surgical strategies for ocular surface reconstruction]. Ophthalmologe (2011) 0.76
[Antiangiogenic therapy at the ocular surface: when, what and why?]. Ophthalmologe (2011) 0.76
Editors' pick 2009. Br J Clin Pharmacol (2010) 0.75
Delivery is key: lessons learnt from developing splice-switching antisense therapies. EMBO Mol Med (2017) 0.75
Drops for corneal neovascularization. Ophthalmology (2010) 0.75
[Biologics: from the "golden calf" to a "gold standard"?]. Ophthalmologe (2011) 0.75
Serial optical coherence tomography angiography for corneal vascularization. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
[Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva]. Ophthalmologe (2009) 0.75
The IC3D classification of the corneal dystrophies. Cornea (2008) 3.46
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea (2006) 3.18
Identification and characterization of limbal stem cells. Exp Eye Res (2005) 2.38
Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci (2004) 2.27
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol (2009) 1.98
Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol (2009) 1.97
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res (2013) 1.84
Comparison of dynamic contour tonometry with goldmann applanation tonometry. Invest Ophthalmol Vis Sci (2004) 1.78
Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet (2009) 1.71
Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci (2008) 1.71
Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol (2012) 1.68
Pressure-induced interlamellar stromal keratitis after laser in situ keratomileusis. Cornea (2011) 1.66
Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea (2006) 1.66
Recurrent corneal erosion syndrome. Surv Ophthalmol (2008) 1.58
Retinal nerve fiber layer thickness in normals measured by spectral domain OCT. J Glaucoma (2010) 1.55
Comparison of the Colvard, Procyon, and Neuroptics pupillometers for measuring pupil diameter under low ambient illumination. J Refract Surg (2010) 1.53
Comparison of scanning laser polarimetry and optical coherence tomography in quantitative retinal nerve fiber assessment. J Glaucoma (2010) 1.53
Histologic analysis of descemet stripping in posterior lamellar keratoplasty. Arch Ophthalmol (2008) 1.52
Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea (2008) 1.51
Reproducibility of graft preparations in Descemet's membrane endothelial keratoplasty. Ophthalmology (2013) 1.51
Intraocular pressure measurements using dynamic contour tonometry after laser in situ keratomileusis. Invest Ophthalmol Vis Sci (2003) 1.48
Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology (2002) 1.48
New insights into changes in corneal thickness in healthy mountaineers during a very-high-altitude climb to Mount Muztagh Ata. Arch Ophthalmol (2010) 1.48
Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology (2010) 1.46
Corneal limbal microenvironment can induce transdifferentiation of hair follicle stem cells into corneal epithelial-like cells. Stem Cells (2009) 1.46
Salzmann's nodular degeneration of the cornea: a review and case series. Cornea (2005) 1.43
Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents. Graefes Arch Clin Exp Ophthalmol (2012) 1.42
MoisturePlus contact lens solution as a source of acanthamoeba keratitis. Cornea (2009) 1.42
[Lamellar keratoplasty - new concepts]. Klin Monbl Augenheilkd (2004) 1.42
Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT. Invest Ophthalmol Vis Sci (2009) 1.41
Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol (2006) 1.41
Tumors of the lacrimal drainage system. Orbit (2010) 1.40
IC3D classification of corneal dystrophies--edition 2. Cornea (2015) 1.39
Decreased keratocyte death after laser-assisted subepithelial keratectomy and photorefractive keratectomy in rabbits. J Cataract Refract Surg (2004) 1.39
Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol (2008) 1.38
The Pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology (2005) 1.36
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol (2012) 1.34
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol (2002) 1.33
Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (2005) 1.33
Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer. Invest Ophthalmol Vis Sci (2008) 1.30
Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology (2010) 1.29
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol (2007) 1.29
Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol (2008) 1.27
Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int (2011) 1.26
Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci (2005) 1.23
From hair to cornea: toward the therapeutic use of hair follicle-derived stem cells in the treatment of limbal stem cell deficiency. Stem Cells (2011) 1.22
Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol (2002) 1.22
Measurement of accommodation after implantation of an accommodating posterior chamber intraocular lens. J Cataract Refract Surg (2003) 1.22
Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci (2006) 1.18
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2009) 1.18
Overexpression of Insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci (2003) 1.18
Late bacterial keratitis after implantation of intrastromal corneal ring segments. J Cataract Refract Surg (2003) 1.18
Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol (2007) 1.16
Long-term outcome of excimer laser phototherapeutic keratectomy for treatment of Salzmann's nodular degeneration. J Cataract Refract Surg (2005) 1.16
Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol (2010) 1.15
Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet (2010) 1.14
Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty. Ophthalmology (2011) 1.14
25-, 23-, and 20-gauge vitrectomy in epiretinal membrane surgery: a comparative study of 553 cases. Graefes Arch Clin Exp Ophthalmol (2011) 1.13
Gap junctional communication in microinjected human limbal and peripheral corneal epithelial cells cultured on intact amniotic membrane. Exp Eye Res (2003) 1.13
Comparison and reproducibility of corneal thickness and curvature readings obtained by the Galilei and the Orbscan II analysis systems. J Cataract Refract Surg (2008) 1.11
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med (2011) 1.10
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea (2012) 1.10
Preservation of the limbal stem cell phenotype by appropriate culture techniques. Invest Ophthalmol Vis Sci (2009) 1.09
Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol (2005) 1.09
Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry. Arch Ophthalmol (2006) 1.09
Implantation of a new accommodative posterior chamber intraocular lens. J Refract Surg (2002) 1.08
Stability of refraction, accommodation, and lens position after implantation of the 1CU accommodating posterior chamber intraocular lens. J Cataract Refract Surg (2003) 1.07
Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci (2011) 1.07
Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss. Invest Ophthalmol Vis Sci (2004) 1.07
Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus. Cornea (2012) 1.07
Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol (2011) 1.07
Expression of Delta Np63 in response to phorbol ester in human limbal epithelial cells expanded on intact human amniotic membrane. Invest Ophthalmol Vis Sci (2003) 1.07
Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand (2004) 1.06
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol (2006) 1.06
Measuring contrast sensitivity in normal subjects with OPTEC 6500: influence of age and glare. Graefes Arch Clin Exp Ophthalmol (2007) 1.05
Pupillographic measurements with pattern stimulation: the pupil's response in normal subjects and first measurements in glaucoma patients. Invest Ophthalmol Vis Sci (2006) 1.05
Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.05
Corneal biomechanical properties in exfoliation syndrome and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol (2012) 1.05
Characterization of the corneal surface in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium. Ophthalmology (2009) 1.05
Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci (2009) 1.04
Midterm results of cultivated autologous and allogeneic limbal epithelial transplantation in limbal stem cell deficiency. Dev Ophthalmol (2010) 1.04
LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. Ophthalmology (2012) 1.02
Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study. Transpl Int (2005) 1.02
Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci (2009) 1.02
Combination of transepithelial phototherapeutic keratectomy and autologous serum eyedrops for treatment of recurrent corneal erosions. J Cataract Refract Surg (2005) 1.02
Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma (2007) 1.02
Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol (2010) 1.02
Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea (2008) 1.02
High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol (2003) 1.02
Corneal endothelial cell loss after nonmechanical penetrating keratoplasty depends on diagnosis: a regression analysis. Graefes Arch Clin Exp Ophthalmol (2002) 1.02
In vivo confocal microscopy in fungal keratitis. Br J Ophthalmol (2006) 1.01
Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res (2003) 1.01